Computer Vision News - December 2021

41 Positrigo late, it’s harder to treat, ” Jannis points out. “ This is a game changer for an ageing society because it makes it possible to diagnose early and intervene early. There are hundreds of medications in different phases of clinical trials. ” He is confident there is now a clear path to market. Positrigo has worked closely with clinicians and engineers to validate the technology and aims to make it available in the next one to two years. It is entering a new series B funding round next year to support roll out into its first markets in Germany, Switzerland, and the US. The hope is that in a decade’s time it will be widely available for everyone at the point of care. Positrigo doesn’t intend to stop here. This hardware is at the core of a software platform it is developing, and with the images it gets it is devising new models with AI-driven data science to help doctors make better diagnoses. “ Compared to current software, this will have an improved user experience and usability , ” Jannis reveals. “ If you make it nice and easy to use, that’s also part of the road to making this exam more accessible and available. ” Positrigo is hiring! Visit its website for current openings and look out for new software engineer positions next year. If you have other engineering disciplines, keep an eye on their page for future roles. intravenous injection with a small dose of radioactive tracer . The radiation dose is no higher than is needed for current systems, which is already no more than someone would be exposed to on a transatlantic flight. The brain scan can also identify other brain-degenerative diseases, such as Parkinson’s and ALS , to get an individual assessment of someone’s risk of brain function decline. “ Early diagnosis is vital because if you’re too